Cartesian Therapeutics, Inc. · GETTEX:1S70
Cartesian Therapeutics, Inc. shareholders
As of Sep 30, 2026, 96 institutions reported holding Cartesian Therapeutics, Inc., 28.7% of its shares. Largest: Squarepoint Ops LLC, BlackRock and 683 Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cartesian Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Squarepoint Ops LLC | 2.26M | 7.4% | +8,611 | Nov 9, 2026 |
| BlackRock | 808K | 2.7% | −10,781 | Nov 13, 2026 |
| 683 Capital Management, LLC | 751K | 2.5% | +101K | Nov 16, 2026 |
| Vanguard | 740K | 2.4% | +1,401 | Nov 13, 2026 |
| Fidelity | 370K | 1.2% | +2,028 | Nov 10, 2026 |
| Two Sigma | 367K | 1.2% | +71,057 | Nov 16, 2026 |
| Geode Capital | 343K | 1.1% | −13,696 | Nov 6, 2026 |
| AQR Capital Management LLC | 287K | 0.94% | −69,300 | Nov 16, 2026 |
| State Street | 262K | 0.86% | +12,524 | Nov 12, 2026 |
| Marshall Wace, LLP | 244K | 0.80% | +10,626 | Nov 13, 2026 |